As schools return from their summer breaks, there is widespread concern amongst parents and teachers alike. Swine Flu (H1N1) thrives off the conditions typical in classrooms and younger demographics are particularly vulnerable. As manufacturers struggle to meet unprecedented demand, one company has a controversial idea.
According to Robert Melamede, CEO of Cannabis Science, the answer to this crisis may be found in a medicinal throat lozenge made from marijuana. Altough Mr. Melamede idea to administer his lozenge to children and to teens, may seem like a ridiculous idea, the medical reasons behind his approach may very well be quite sound.
Melamede is quoted by ABC News as saying: “Contemporary antiviral medical technology is currently inadequate to meet the world’s immediate challenges….we believe that cannabis extract-based medicines can reduce influenza deaths.”
Marijuana has long been known to suppress the immune system as it cotains natural, plant-based cannabinoids called phytocannabinoids, similar to the natural endocannabinoids released by the body during severe inflammations.
Last month, Cannabis Science, the company announced that it is seeking FDA approval for its flu-fighting lozenges – they may be on to something here!